ARTERRA BIOSCIENCE SPA (ARBS.MI) Stock Price & Overview

BIT:ARBSIT0005386369

Current stock price

2.72 EUR
-0.22 (-7.48%)
Last:

The current stock price of ARBS.MI is 2.72 EUR. Today ARBS.MI is down by -7.48%. In the past month the price decreased by -16.56%.

ARBS.MI Key Statistics

1-Month Range2.7 - 3.48
Current ARBS.MI stock price positioned within its 1-month range.
Market Cap
18.115M
P/E
9.07
Fwd P/E
N/A
EPS (TTM)
0.30
Dividend Yield
4.64%

ARBS.MI Stock Performance

Today
-7.48%
1 Week
-17.07%
1 Month
-16.56%
3 Months
+15.25%
Longer-term
6 Months N/A
1 Year N/A
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A

ARBS.MI Stock Chart

ARTERRA BIOSCIENCE SPA / ARBS Daily stock chart

ARBS.MI Technical Analysis

ChartMill assigns a technical rating of 3 / 10 to ARBS.MI.


Chartmill TA Rating
Chartmill Setup Rating

ARBS.MI Fundamental Analysis

ChartMill assigns a fundamental rating of 7 / 10 to ARBS.MI. ARBS.MI has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ARBS.MI Earnings

Next Earnings DateN/A
Last Earnings DateN/A
PeriodQ2 / 2025
EPS Reported
Revenue Reported
EPS Surprise %
Revenue Surprise %

ARBS.MI Forecast & Estimates

7 analysts have analysed ARBS.MI and the average price target is 3.88 EUR. This implies a price increase of 42.5% is expected in the next year compared to the current price of 2.72.


Analysts
Analysts82.86
Price Target3.88 (42.65%)
EPS Next YN/A
Revenue Next YearN/A

ARBS.MI Groups

Sector & Classification

Sub-Industry
Biotechnology
Index Membership

ARBS.MI Financial Highlights

Over the last trailing twelve months ARBS.MI reported a non-GAAP Earnings per Share(EPS) of 0.3. The EPS increased by 37.48% compared to the year before.


Income Statements
Revenue(TTM)4.49M
Net Income(TTM)1.90M
Industry RankSector Rank
PM (TTM) 42.38%
ROA 13.59%
ROE 16.33%
Debt/Equity 0.02
Chartmill High Growth Momentum
EPS Q2Q%109.79%
Sales Q2Q%14.28%
EPS 1Y (TTM)37.48%
Revenue 1Y (TTM)13.44%

ARBS.MI Ownership

Ownership
Inst Owners0.16%
Shares6.66M
Float2.64M
Ins Owners46.87%
Short Float %N/A
Short RatioN/A

About ARBS.MI

Company Profile

ARBS logo image Arterra Bioscience SpA is engaged in research and development activities in the field of living organisms such as bacteria, yeasts, and plant and animal cells. The company is headquartered in Naples, Napoli and currently employs 37 full-time employees. The company went IPO on 2019-10-28. The firm focuses on research and development of ingredients and natural solutions. By exploiting the potentialities of living organisms such as bacteria, yeasts, plants and animal cells, the Company develops products and processes that serve as enabling technologies and that find horizontal application in various industrial sectors, such as cosmetics, agriculture and nutraceutics. The Company’s main activities and applications include development of technological platforms, employed in the screening of active compounds for different industrial applications; setting up of new extraction processes, aimed at improving the sustainability and yield of interesting compounds and the production of high-tech raw materials with application in different industrial fields. The firm collaborates with private companies, universities and research institutes all over the world.

Company Info

IPO: 2019-10-28

ARTERRA BIOSCIENCE SPA

via Benedetto Brin, 69

Naples NAPOLI IT

Employees: 34

ARBS Company Website

ARBS Investor Relations

Phone: 390816584411

ARTERRA BIOSCIENCE SPA / ARBS.MI FAQ

Can you describe the business of ARTERRA BIOSCIENCE SPA?

Arterra Bioscience SpA is engaged in research and development activities in the field of living organisms such as bacteria, yeasts, and plant and animal cells. The company is headquartered in Naples, Napoli and currently employs 37 full-time employees. The company went IPO on 2019-10-28. The firm focuses on research and development of ingredients and natural solutions. By exploiting the potentialities of living organisms such as bacteria, yeasts, plants and animal cells, the Company develops products and processes that serve as enabling technologies and that find horizontal application in various industrial sectors, such as cosmetics, agriculture and nutraceutics. The Company’s main activities and applications include development of technological platforms, employed in the screening of active compounds for different industrial applications; setting up of new extraction processes, aimed at improving the sustainability and yield of interesting compounds and the production of high-tech raw materials with application in different industrial fields. The firm collaborates with private companies, universities and research institutes all over the world.


What is the stock price of ARTERRA BIOSCIENCE SPA today?

The current stock price of ARBS.MI is 2.72 EUR. The price decreased by -7.48% in the last trading session.


What is the dividend status of ARTERRA BIOSCIENCE SPA?

ARTERRA BIOSCIENCE SPA (ARBS.MI) has a dividend yield of 4.64%. The yearly dividend amount is currently 0.11.


What is the ChartMill rating of ARTERRA BIOSCIENCE SPA stock?

ARBS.MI has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 7 out of 10.


Where is ARTERRA BIOSCIENCE SPA (ARBS.MI) stock traded?

ARBS.MI stock is listed on the Euronext Milan exchange.


What sector and industry does ARTERRA BIOSCIENCE SPA belong to?

ARTERRA BIOSCIENCE SPA (ARBS.MI) operates in the Health Care sector and the Biotechnology industry.


Can you provide the ownership details for ARBS stock?

You can find the ownership structure of ARTERRA BIOSCIENCE SPA (ARBS.MI) on the Ownership tab.